HAE
HAE
NYSE · Health Care

Haemonetics Corp/Mass

$55.93
-0.73 (-1.29%)
Financial Highlights (FY 2026)
Revenue
1.31B
Net Income
160.97M
Gross Margin
56.1%
Profit Margin
12.3%
Rev Growth
+11.1%
D/E Ratio
1.49
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 56.1% 56.1% 54.3% 54.3%
Operating Margin 16.3% 14.7% 11.5% 11.0%
Profit Margin 12.3% 11.7% 7.9% 6.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.31B 1.18B 2.17B 1.94B
Gross Profit 733.01M 659.95M 1.18B 1.05B
Operating Income 212.94M 172.55M 248.79M 212.97M
Net Income 160.97M 130.43M 171.22M 125.72M
Gross Margin 56.1% 56.1% 54.3% 54.3%
Operating Margin 16.3% 14.7% 11.5% 11.0%
Profit Margin 12.3% 11.7% 7.9% 6.5%
Rev Growth +11.1% +11.1% +24.6% +5.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 893.56M 893.56M 666.77M 805.22M
Total Equity 598.86M 598.86M 1.73B 1.53B
D/E Ratio 1.49 1.49 0.39 0.53
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 259.27M 221.76M 302.84M 250.08M
Free Cash Flow 163.13M 182.49M